PanCareSurPass Project HL7 FHIR Implementation Guide
1.0.0 - release 150

PanCareSurPass Project HL7 FHIR Implementation Guide, published by PanCareSurPass Project. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/pcsp/ and changes regularly. See the Directory of published versions

ValueSet: Conditions at risk

Official URL: http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-riskcondition-eu-pcsp Version: 1.0.0
Active as of 2025-10-16 Computable Name: RiskCondition

Condition at risk proposed by the PCSP algorithm

References

Logical Definition (CLD)

 

Expansion

Expansion performed internally based on codesystem PCSP Conditions at risk v1.0.0 (CodeSystem)

This value set contains 47 concepts

SystemCodeDisplay (en)JSONXML
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  1Subsequent thyroid cancer
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  2Subsequent breast cancer
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  3Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia)
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  4Impaired fertility Impaired spermatogenesis
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  5Testosterone deficiency
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  6Physical sexual dysfunction
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  7Premature ovarian insufficiency
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  8Ear problems
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  9Impaired glucose metabolism and diabetes melitus
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  10Dyslipidemia
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  11Overweight and obesity
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  12Hypertension
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  13Reduced bone mineral density
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  14Osteonecrosis
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  15Hypothalamic-pituitary (HP) axis problems (High risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD)
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  16Hypothalamic-pituitary (HP) axis problems (Standard risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD)
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  17Central precocious puberty (CPP) For girls with age below 8 years
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  18Central precocious puberty (CPP) For boys with age below 9 yearss
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  19Thyroid function problems
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  20Cerebrovascular problem
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  21Neurocognitive problems
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  22Peripheral neuropathy
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  23Cataract
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  24Eye problems
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  25Craniofacial growth problems
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  26Spine scoliosis and kyphosis
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  27Lower urinary tract problems
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  28Obstetric problems
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  29Dental and oral problems
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  30Gastro-intestinal problems
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  31Arrhythmia
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  32Pulmonary problems
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  33Renal problems (Glomerular dysfunction - Tubular dysfunction)
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  34Liver problems
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  35Iron overload
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  36Spleen problems
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  37Tumor predisposition
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  38Subsequent melanoma and non-melanoma skin cancer
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  39Subsequent colorectal cancer
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  40Subsequent Oral Cancer
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  41Subsequent acute myeloid leukaemia or myelodysplasia
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  42Subsequent bladder cancer
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  43Subsequent Bone Cancer
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  44Subsequent lung cancer
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  45Subsequent CNS neoplasms
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  46Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia)
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp  47Renal problems (Tubular dysfunction)

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code